desipramine has been researched along with Hepatocellular Carcinoma in 1 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, anti-proliferative effects of desipramine, a tricyclic antidepressant, in hepatocellular carcinoma are currently unknown." | 7.85 | Desipramine induces apoptosis in hepatocellular carcinoma cells. ( Kim, SJ; Yang, DK, 2017) |
| " However, anti-proliferative effects of desipramine, a tricyclic antidepressant, in hepatocellular carcinoma are currently unknown." | 3.85 | Desipramine induces apoptosis in hepatocellular carcinoma cells. ( Kim, SJ; Yang, DK, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, DK | 1 |
| Kim, SJ | 1 |
1 other study available for desipramine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Desipramine induces apoptosis in hepatocellular carcinoma cells.
Topics: Antidepressive Agents, Tricyclic; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Desipram | 2017 |